Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
50.57
Dollar change
+0.76
Percentage change
1.53
%
IndexRUT P/E83.85 EPS (ttm)0.60 Insider Own21.11% Shs Outstand17.49M Perf Week-2.47%
Market Cap1.03B Forward P/E11.86 EPS next Y4.26 Insider Trans-14.86% Shs Float16.12M Perf Month-17.99%
Income11.76M PEG38.11 EPS next Q0.78 Inst Own67.62% Short Float / Ratio2.34% / 2.23 Perf Quarter-21.69%
Sales449.39M P/S2.30 EPS this Y225.74% Inst Trans2.88% Short Interest0.38M Perf Half Y5.35%
Book/sh21.07 P/B2.40 EPS next Y-3.76% ROA1.64% Target Price71.00 Perf Year20.55%
Cash/sh9.45 P/C5.35 EPS next 5Y2.20% ROE3.49% 52W Range36.36 - 65.89 Perf YTD25.70%
Dividend- P/FCF17.20 EPS past 5Y-102.25% ROI1.59% 52W High-23.25% Beta0.89
Dividend %- Quick Ratio2.91 Sales past 5Y13.49% Gross Margin50.27% 52W Low39.08% ATR1.97
Employees600 Current Ratio3.70 Sales Q/Q57.27% Oper. Margin10.20% RSI (14)37.24 Volatility3.05% 4.15%
OptionableYes Debt/Eq0.72 EPS Q/Q190.24% Profit Margin2.62% Rel Volume0.95 Prev Close49.81
ShortableYes LT Debt/Eq0.72 EarningsNov 08 BMO Payout- Avg Volume169.05K Price50.57
Recom1.00 SMA20-6.38% SMA50-10.95% SMA200-0.15% Volume160,791 Change1.53%
Date Action Analyst Rating Change Price Target Change
Aug-22-23Reiterated H.C. Wainwright Buy $60 → $73
Mar-01-23Initiated Guggenheim Buy $55
Sep-07-22Initiated H.C. Wainwright Buy $50
Nov-02-21Initiated Truist Buy $70
May-07-20Downgrade Cantor Fitzgerald Overweight → Neutral
Sep-12-19Initiated Guggenheim Buy
May-10-19Downgrade Raymond James Strong Buy → Outperform $73 → $82
Oct-16-17Reiterated Canaccord Genuity Buy $60 → $66
Jul-31-17Initiated Canaccord Genuity Buy $60
Feb-22-17Downgrade ROTH Capital Buy → Neutral
Nov-22-23 09:26AM
Nov-19-23 07:00AM
Nov-17-23 05:11AM
Nov-09-23 09:42AM
Nov-08-23 03:11PM
09:30AM Loading…
09:30AM
07:08AM
06:50AM
Nov-02-23 10:00AM
Nov-01-23 06:00PM
10:01AM
Oct-30-23 06:50AM
Oct-25-23 06:50AM
Oct-20-23 06:00PM
Oct-19-23 06:15PM
06:00PM Loading…
Oct-13-23 06:00PM
Oct-06-23 06:00PM
Oct-05-23 06:15PM
Oct-02-23 06:50AM
Sep-29-23 06:00PM
Sep-22-23 04:19AM
Sep-21-23 06:00PM
Sep-20-23 06:15PM
Sep-18-23 04:05PM
Sep-14-23 06:00PM
Sep-12-23 06:50AM
Sep-11-23 02:43PM
Sep-08-23 08:50AM
Aug-29-23 09:15AM
Aug-28-23 06:50AM
12:00PM Loading…
Aug-25-23 12:00PM
10:00AM
06:39AM
Aug-24-23 06:50AM
Aug-23-23 08:50AM
06:50AM
Aug-16-23 09:15AM
Aug-11-23 09:40AM
Aug-10-23 09:15AM
Aug-09-23 09:30AM
08:15AM
07:06AM
06:50AM
Jul-31-23 11:06AM
07:17AM
Jul-24-23 06:00PM
Jul-18-23 06:00PM
09:40AM
Jul-11-23 06:15PM
Jun-27-23 07:12AM
Jun-22-23 09:40AM
Jun-21-23 08:00PM
09:15AM
Jun-20-23 11:31AM
Jun-06-23 12:37PM
09:40AM
May-22-23 06:34PM
May-18-23 09:40AM
May-16-23 04:05PM
May-15-23 06:50AM
May-12-23 07:03AM
May-11-23 04:01PM
May-09-23 02:32AM
May-08-23 01:17PM
08:05AM
06:50AM
Apr-27-23 06:50AM
Apr-26-23 08:00PM
04:15PM
Apr-24-23 06:50AM
Apr-15-23 09:08AM
Apr-04-23 06:50AM
Mar-13-23 07:06AM
Mar-09-23 11:45PM
08:05AM
06:50AM
Mar-02-23 10:00AM
Mar-01-23 04:16PM
Feb-28-23 05:35PM
Feb-22-23 04:05PM
Feb-07-23 06:39AM
Dec-22-22 07:19AM
Dec-19-22 04:56PM
Nov-28-22 06:50AM
Nov-27-22 09:31AM
Nov-16-22 06:50AM
Nov-11-22 05:25AM
Nov-09-22 08:05AM
06:50AM
Oct-24-22 06:50AM
Sep-12-22 06:50AM
Aug-31-22 06:59AM
Aug-30-22 04:05PM
Aug-29-22 06:50AM
Aug-16-22 06:50AM
Aug-08-22 08:05AM
06:50AM
Aug-04-22 01:15PM
Aug-03-22 06:50AM
Aug-02-22 10:00AM
ANI Pharmaceuticals, Inc. is a bio-pharmaceutical company, which engages in developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended release and combination products. The company was founded on August 29, 1996 and is headquartered in Baudette, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSNov 17Sale51.0013,000663,000982,620Nov 20 09:05 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSNov 16Sale51.666,448333,104996,430Nov 16 06:11 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSNov 15Sale53.647,647410,1851,002,878Nov 16 06:11 PM
Davis KristaSVP, CHIEF HR OFFICERNov 15Sale53.812,622141,09032,587Nov 16 06:13 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSNov 14Sale53.1722,0951,174,7911,010,525Nov 16 06:11 PM
Mutz ChristopherHEAD OF RARE DISEASENov 10Sale52.473,000157,41063,607Nov 13 04:02 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSOct 19Sale57.0610,000570,6001,032,620Oct 19 04:28 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSOct 18Sale57.786,242360,6631,042,620Oct 19 04:28 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSOct 17Sale58.538,758512,6061,048,862Oct 19 04:28 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSOct 16Sale58.3113,063761,7041,057,620Oct 17 04:32 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSOct 13Sale57.5811,937687,3321,070,683Oct 17 04:32 PM
Gassert ChadSVP - CORP. DEV. & STRATEGYOct 02Sale56.4820,0001,129,600293,226Oct 03 08:00 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSSep 19Sale61.2325,3331,551,1401,082,620Sep 19 05:14 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSSep 18Sale61.648,425519,3171,107,953Sep 19 05:14 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSSep 15Sale62.8116,2421,020,1601,116,378Sep 19 05:14 PM
Gassert ChadSVP - CORP. DEV. & STRATEGYSep 01Sale64.7020,0001,294,000313,226Sep 05 05:06 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSAug 29Sale63.3725,0001,584,2501,132,620Aug 30 04:29 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSAug 28Sale63.0625,0001,576,5001,157,620Aug 30 04:29 PM
Gutwerg OriSVP, GENERICSAug 23Option Exercise31.4913,502425,17876,476Aug 25 04:22 PM
Marken James G.SVP OPS & PROD DEVAug 23Option Exercise38.255,417207,224137,044Aug 25 04:17 PM
Gutwerg OriSVP, GENERICSAug 23Sale62.3915,561970,85160,915Aug 25 04:22 PM
Marken James G.SVP OPS & PROD DEVAug 23Sale63.003,932247,716133,112Aug 25 04:17 PM
MERIDIAN VENTURE PARTNERS II L10% OwnerAug 16Sale58.50200,00011,700,0001,819,259Aug 16 08:00 PM
Lalwani NikhilPRESIDENT & CEOAug 15Option Exercise29.0011,616336,864365,006Aug 15 08:39 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSAug 15Sale61.6022,1101,361,9761,182,620Aug 16 07:07 PM
Lalwani NikhilPRESIDENT & CEOAug 15Sale61.1311,616710,086353,390Aug 15 08:39 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSAug 14Sale61.1527,8901,705,4741,204,730Aug 16 07:07 PM
CAREY STEPHEN P.SVP & CFOAug 14Sale61.3717,6391,082,505155,839Aug 16 04:24 PM
Pera Antonio RDirectorAug 14Sale60.373,000181,11033,627Aug 15 08:45 PM
Lalwani NikhilPRESIDENT & CEOAug 11Sale57.7556,6663,272,462353,390Aug 15 08:39 PM
Gassert ChadSVP - CORP. DEV. & STRATEGYAug 01Sale51.0620,0001,021,200333,226Aug 03 06:03 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJul 21Sale52.5611,500604,4401,232,620Jul 21 07:15 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJul 20Sale51.526,000309,1201,244,120Jul 21 07:15 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJul 19Sale51.485,969307,2841,250,120Jul 21 07:15 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJul 18Sale51.846,700347,3281,256,089Jul 18 08:06 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJul 17Sale51.069,831501,9711,262,789Jul 18 08:06 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJul 14Sale50.4310,000504,3001,272,620Jul 18 08:06 PM
Gassert ChadSVP - CORP. DEV. & STRATEGYJul 03Sale53.4320,0001,068,600353,226Jul 06 04:15 PM
Gassert ChadSVP - CORP. DEV. & STRATEGYJun 22Sale51.3220,0001,026,400373,226Jun 23 08:00 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJun 22Sale51.3813,500693,6307,407Jun 22 08:00 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJun 21Sale51.9511,843615,24420,907Jun 22 08:00 PM
Shanmugam MuthusamyHEAD OF R&D, COO-NOVITIUM OPSJun 20Sale51.9314,657761,13832,750Jun 22 08:00 PM